We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
Registrars:
Key Personnel
CEO:
Emma Walmsley
Non-Executive Director:
Jeannie Lee , Gavin Screaton, Hal Barron , Wendy Becker
Non-Executive Chairman:
Jonathan Symonds
Senior Independent Non-Executive Director:
Charles Bancroft
Chief Finance Officer:
Julie Brown
Independent Non-Executive Director:
Vishal Sikka, Jesse Goodman, Elizabeth (Liz) McKee Anderson, Anne Beal, Harry (Hal) C. Dietz